Purpose COVID-19 is characterized by dysfunctional immune responses and metabolic
derangements, which in some, lead to multi-organ failure and death. Statins are …

The coronavirus disease-2019 (COVID-19) is caused by SARS-CoV-2, leading to acute
respiratory distress syndrome (ARDS), thrombotic complications, and myocardial injury …

Background Statins are frequently prescribed for patients with dyslipidemia and diabetes
mellitus. These comorbidities are highly prevalent in coronavirus disease 2019 (COVID-19) …

Background There is an urgent need for novel therapeutic strategies for reversing COVID-19-
related lung inflammation. Recent evidence has demonstrated that the cholesterol-lowering …

Objective To determine the association between chronic statin use and mortality in patients
hospitalized with coronavirus disease 2019 (COVID-19). Patients and Methods We identified …

Background and aims Statin therapy is administered to patients with high cardiovascular
risk. These patients are also at risk for severe course of coronavirus disease 2019 (COVID …

Abstract Background Coronavirus disease-19 (COVID-19) infection is associated with an
uncontrolled systemic inflammatory response. Statins, given their anti-inflammatory …

Purpose Previously, we have reported potential clinical benefits with the use of statins in
patients with coronavirus disease 2019 (COVID-19) in a meta-analysis, where there was a …

Aims and objectives Statins have been proposed as potentially useful agents for modulating
the host response in COVID-19. However, solid evidence-based recommendations are still …

Background Coronavirus disease 2019 (COVID-19) might affect everyone, but people with
comorbidities such as hypertension and cardiovascular disease (CVD) may often have more …